Stay informed. See UMDF information on COVID-19.
Energy for Life
Family Impact Fund
2018 – MCN Established
The Mitochondrial Care Network (MCN) was established to optimize patient care.
Mito Champion Spotlight
Advocacy Update – March 2023: Federal Appropriations 101 and Why Advocacy Matters for Mito
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.
Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhD
Advocacy Update – February 2023: Could ARPA-H Change the Research Landscape for Rare Diseases?
2018 – UMDF Hires New CEO
2019 – FDA Meeting for Patient Families